매상 변화 날짜
Acadia Pharmaceuticals USD 342M 34.04M 2026-09
Agios Pharmaceuticals USD 55.38M 10.64M 2026-09
Akebia Therapeutics USD 57.62M 1.14M 2025-12
Amgen USD 10.4B 300M 2026-09
AstraZeneca USD 16.21B 830M 2026-09
Bayer EUR 10.05B 820M 2026-09
BioMarin Pharmaceutical USD 1.03B 40M 2026-09
Bristol-Myers Squibb USD 13.07B 100M 2026-09
Cytokinetics USD 47.6M 19M 2026-09
Eisai JPY 235.63B 1.3B 2026-09
Eli Lilly USD 24.4B 1.43B 2026-09
Exelixis USD 658.69M 30M 2026-09
Genmab DKK 1.16B 259M 2026-06
Glaxosmithkline GBP 8.89B 1.2B 2026-09
Incyte USD 1.56B 110M 2026-09
Ionis Pharmaceuticals USD 243M 25M 2026-09
MacroGenics USD 32.83M 12.03M 2026-06
Merck USD 18.1B 1.5B 2026-09
Moderna USD 1.31M 98.69M 2026-09
Nektar Therapeutics USD 10.86M 10.95M 2026-03
Neurocrine Biosciences USD 1.12B 161M 2026-09
Novartis USD 14.52B 112M 2026-09
Pfizer USD 16.6B 1.57B 2026-09
Puma Biotechnology USD 80.54M 33.46M 2024-09
Sanofi EUR 12.3B 160M 2026-06
Takeda JPY 1.19T 32.9B 2026-09
Ultragenyx Pharmaceutical USD 173M 41M 2026-09
Xencor USD 116.52M 65.3M 2026-09